Siewert Type II Adenocarcinoma of Esophagogastric Junction Clinical Trial
Official title:
Siewert Type II Esophageal Adenocarcinoma: on the Relationship Between Histology, Esophageal-gastric Intestinal Metaplasia and Gastric Greater Curvature Lymphatic Metastases, Survival
In Siewert type II adenocarcinoma, the relationship between adenocarcinoma sub types and survival, histologic/biologic patterns related to the presence/absence of gastric greater curvature metastases, were investigated.
In order to achieve further data on the biological patterns of intestinal and diffuse subtypes of esophageal adenocarcinoma (Lauren's classification), on the frequency of gastric greater curvature nodal stations and on the clinical relevance, in terms of prognosis and survival, of these parameters, a Siewert type II case series of Siewert type II adenocarcinomas, submitted to primary (no neoadjuvant therapy) surgical, studied, operated upon and followed up, were analysed. According to histologic patterns, cases were ordered in intestinal and diffuse adenocarcinoma sub types (Lauren's classification)and distinguished in Barret's, cardiopyloric, gastric types. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04151524 -
Classification of Adenocarcinoma of the Esophagogastric Junction
|
||
Not yet recruiting |
NCT06044311 -
Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
|
Phase 2 | |
Recruiting |
NCT05356520 -
Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction
|
N/A | |
Recruiting |
NCT04423354 -
A Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Ⅱ AEG
|
N/A | |
Recruiting |
NCT02313688 -
Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors
|
N/A |